1887

Abstract

Summary

An analysis is made of the antibody response to Phase-1 and Phase-2 antigens, as measured by immunofluorescence in the IgM, IgG or IgA immunoglobulin classes, or by complement-fixation, in patients with acute and chronic Q fever and in vaccinated or skin-tested subjects. In acute (primary) Q fever, IgM specific antibodies to Phase-1 antigen are present in early convalescence together with IgM, IgG, IgA and CF antibodies to Phase-2 antigen. IgM specific antibody may persist for at least 678 days after onset of the acute illness. Patients with chronic Q fever have no IgM specific antibody to Phase-1 or -2 antigens, or only at very low levels; high levels of specific antibody in the IgG and IgA classes, together with CF antibody to both antigenic phases, appear to be characteristic. The serological response in initially seronegative, vaccinated subjects is mainly to Phase-1 antigen in the IgM fraction, and to a lesser degree to Phase-2 antigen by CF and in IgM and IgG classes. Subjects who were equivocally seropositive before vaccination showed IgA and IgG specific antibody responses to Phase-1 antigen and CF and IgG class responses to Phase-2 antigen. Similar antibody profiles were observed in patients who seroconverted after a positive skin-test. Data are also presented on the suitability of antigens for use in immunofluorescence and on the binding of IgM specific antibody by Phase-1 antigen but its failure to fix complement.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-19-3-281
1985-06-01
2022-12-01
Loading full text...

Full text loading...

/deliver/fulltext/jmm/19/3/medmicro-19-3-281.html?itemId=/content/journal/jmm/10.1099/00222615-19-3-281&mimeType=html&fmt=ahah

References

  1. Abinanti F R, Marmion B P. 1957; Protective or neutralizing antibody in Q fever. American Journal of Hygiene 66:173–195
    [Google Scholar]
  2. Abraham G N, Clark R A, Vaughan J H. 1972; Characterization of an IgA rheumatoid factor: binding properties and reactivity with the subclasses of human yG globulin. Immunochemistry 9:301–315
    [Google Scholar]
  3. Andrews P S, Marmion B P. 1959; Chronic Q fever. 2. Morbid anatomical and bacteriological findings in a patient with endocarditis. British Medical Journal 2:983–988
    [Google Scholar]
  4. Babudieri B. 1958; Studies on the microscopic slide-agglutination test for Q fever. Bulletin of the World Health Organisation 19:981–994
    [Google Scholar]
  5. Bell J F, Luoto L, Casey M, Lackman D B. 1964; Serologic and skin-test response after Q fever vaccination by the intracutaneous route. The Journal of Immunology 93:403–408
    [Google Scholar]
  6. Borsos T, Chapuis R M, Langone J J. 1981; Distinction between fixation of C1 and the activation of complement by natural IgM anti-hapten antibody: effect of cell surface hapten density. Molecular Immunology 18:863–868
    [Google Scholar]
  7. Bozeman F M, Elisberg B L. 1963; Serological diagnosis of scrub typhus by indirect immunofluorescence. Proceedings of the Society for Experimental Biology and Medicine 112:568–573
    [Google Scholar]
  8. Bradstreet C M P, Taylor C E D. 1962; Technique of complement-fixation test applicable to the diagnosis of virus diseases. Monthly Bulletin of the Ministry of Health and the Public Health Laboratory Service 21:96–104
    [Google Scholar]
  9. Buckley B. 1980; Q fever epidemic in Victorian general practice. Medical Journal of Australia593–595
    [Google Scholar]
  10. Cowan K M. 1973; Antibody response to viral antigens. Advances in Immunology 17:195–253
    [Google Scholar]
  11. Cracea E, Dumitrescu-Constantinescu S, Botez D, Ioanid L. 1977; Q-fever soluble vaccine effects in Coxiella burneti sensitised humans. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene, 1. Abt Orig A 238:413–418
    [Google Scholar]
  12. Elisberg B L, Bozeman F L. 1966; Serological diagnosis of rickettsial diseases by indirect immunofluorescence. Archives de l’Institut Pasteur de Tunis 43:193–204
    [Google Scholar]
  13. Field P R, Hunt J G, Murphy A M. 1983; Detection and persistence of specific IgM antibody to Coxiella burnetii by enzyme-linked immunosorbent assay: A comparison with immunofluorescence and complement-fixation tests. Journal of Infectious Diseases 148:477–487
    [Google Scholar]
  14. Fiset P, Ormsbee R A, , Silberman R, Peacock M, Spielman S H. 1969; A microagglutination technique for detection and measurement of rickettsial antibodies. Ada Virologica 13:60–66
    [Google Scholar]
  15. Giroud P, Giroud M L. 1944; Agglutination des rickettsies, test de séro-protection et reaction d’hypersensibilité cutanee. Bulletin de la Societe de Pathologie Exotique 37:84–93
    [Google Scholar]
  16. Goldwasser R A, Shepard C C. 1959; Fluorescent antibody methods in the differentiation of murine and epidemic typhus sera; specificity changes resulting from previous immunization. Journal of Immunology 82:373–380
    [Google Scholar]
  17. Halevy M, Goldwasser R A. 1972; Differentiation of Phase I and Phase II Coxiella burneti by means of fluorescent antibody techniques. Israel Journal of Medical Science 8:583–587
    [Google Scholar]
  18. Halle S, Dasch G A, Weiss E. 1977; Sensitive enzyme-linked immunosorbent assay for detection of antibodies against typhus rickettsiae, Rickettsia prowazekii and Rickettsia typhi . Journal of Clinical Microbiology 6:101–110
    [Google Scholar]
  19. Harboe M, Folling I. 1974; Recognition of two distinct groups of human IgM and IgA based on different binding to staphylococci. Scandinavian Journal of Immunology 3:471–482
    [Google Scholar]
  20. Hunt J G, Field P R, Murphy A M. 1983; Immunoglobulin responses to Coxiella burnetii (Q fever): single-serum diagnosis of acute infection, using an immunofluorescence technique. Infection and Immunity 39:977–981
    [Google Scholar]
  21. Kearney R. 1983; Binding of murine IgM and monoclonal IgM/A(k) hybrid anti-type III pneumococcal polysaccharide (SIII) antibodies to staphylococcal protein A. Australian Journal of Experimental Biology and Medical Science 61:91–104
    [Google Scholar]
  22. Kimbrough R C, Ormsbee R A, Peacock M, Rogers W R, Bennetts R W, Raaf J, Krause A, Gardner C. 1979; Q-fever endocarditis in the United States. Annals of Internal Medicine 91:400–402
    [Google Scholar]
  23. Lackman D B, Gilda G, Philip R N. 1964; Application of the radioisotope precipitation test to the study of Q fever in man. Health Lab Science 1:21–28
    [Google Scholar]
  24. Lennette E H, Clark W H, Jensen F W, Toomb C J. 1952; Q fever studies. XV. Development and persistence in man of complement-fixing and agglutinating antibodies to Coxiella burnetii . Journal of Immunology 68:591–598
    [Google Scholar]
  25. Luoto L. 1956; A capillary-tube for antibody against Coxiella burnetii in human, guinea-pig and sheep sera. The Journal of Immunology 77:294–298
    [Google Scholar]
  26. Marmion B P. 1984; Vaccine prophylaxis in the control of abattoir-associated Q fever. Lancet
    [Google Scholar]
  27. McKiel J A, Millar A M. 1968; Serodiagnosis in Q fever with special emphasis on the radioisotope precipitation test. Canadian Journal of Microbiology 14:721–726
    [Google Scholar]
  28. Murphy A M, Magro L. 1980; IgM globulin response in Q fever (Coxiella burneti) infections. Pathology 12:391–396
    [Google Scholar]
  29. Murphy A M, Hunt J G. 1981; Retrospective diagnosis of Q fever in a country abattoir by the use of specific IgM globulin estimations. Medical Journal of Australia 2:326–327
    [Google Scholar]
  30. Ormsbee R A. 1964; An agglutination-resuspension test for Q fever antibodies. The Journal of Immunology 92:159–166
    [Google Scholar]
  31. Peacock M G, Fiset P, Ormsbee R A, Wisseman C L. 1979; Antibody response in man following a small intradermal inoculation with Coxiella burnetii Phase 1 vaccine. Acta Virologica 23:73–81
    [Google Scholar]
  32. Peacock M G, Philip R N, Williams J C, Faulkner R S. 1983; Serological evaluation of Q fever in humans: Enhanced Phase 1 titers of immunoglobulins G and A are diagnostic for Q fever endocarditis. Infection and Immunity 41:1089–1098
    [Google Scholar]
  33. Philip R N, Casper E A, Ormsbee R A, Peacock M G, Burgdorfer W. 1976; Microimmunofluorescence test for the serological study of Rocky Mountain spotted fever and Typhus. Journal of Clinical Microbiology 3:51–61
    [Google Scholar]
  34. Stoker M G P, Fiset P. 1956; Phase variation of the Nine Mile and other strains of Rickettsia burneti . Canadian Jounal of Microbiology 2:310–321
    [Google Scholar]
  35. Tabert G G, Lackman D B. 1965; The radioisotope precipitation test for study of Q fever antibodies in human and animal sera. The Journal of Immunology 94:959–965
    [Google Scholar]
  36. Tokarevich N K, Zhebrun A B, Khazenson S L, Roshchina N G. 1980; Determination of immunoglobulin classes of antibodies against Coxiella burnetii by protein A from Staphylococcus aureus . Acta Virologica 24:218–221
    [Google Scholar]
  37. Wang S-P. 1971; A microimmunofluorescence method. Study of antibody response to TRIC organisms in mice. Nichols R L. Trachomas and related disorders caused by chlamydial agents Excerpta Medica; Amsterdam:273–288
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-19-3-281
Loading
/content/journal/jmm/10.1099/00222615-19-3-281
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error